

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 8.28310673 |
| 2 | desmosome organization (GO:0002934) | 7.06148597 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66402235 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.64185838 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.54243287 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.54243287 |
| 7 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.37349459 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 5.33609679 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.33385099 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.33385099 |
| 11 | cysteine metabolic process (GO:0006534) | 4.95892106 |
| 12 | branched-chain amino acid catabolic process (GO:0009083) | 4.76216639 |
| 13 | biotin metabolic process (GO:0006768) | 4.63225977 |
| 14 | valine metabolic process (GO:0006573) | 4.59150414 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 4.58856297 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.52256413 |
| 17 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.51465470 |
| 18 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.50953816 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35473081 |
| 20 | branched-chain amino acid metabolic process (GO:0009081) | 4.34454296 |
| 21 | plasma lipoprotein particle clearance (GO:0034381) | 4.27723476 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 4.27492375 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.22517117 |
| 24 | short-chain fatty acid metabolic process (GO:0046459) | 4.22453473 |
| 25 | fatty acid elongation (GO:0030497) | 4.22296790 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.21502581 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.21495185 |
| 28 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.20404474 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 4.19801704 |
| 30 | macromolecular complex remodeling (GO:0034367) | 4.19801704 |
| 31 | plasma lipoprotein particle remodeling (GO:0034369) | 4.19801704 |
| 32 | intestinal epithelial cell development (GO:0060576) | 4.19292918 |
| 33 | thioester biosynthetic process (GO:0035384) | 4.17990963 |
| 34 | acyl-CoA biosynthetic process (GO:0071616) | 4.17990963 |
| 35 | fatty acid beta-oxidation (GO:0006635) | 4.16554296 |
| 36 | bile acid biosynthetic process (GO:0006699) | 4.15774012 |
| 37 | cell-substrate junction assembly (GO:0007044) | 4.12257337 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09602849 |
| 39 | regulation of sequestering of triglyceride (GO:0010889) | 4.07925472 |
| 40 | ethanol oxidation (GO:0006069) | 4.06955476 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 4.06519236 |
| 42 | lipid oxidation (GO:0034440) | 4.05674664 |
| 43 | low-density lipoprotein particle clearance (GO:0034383) | 4.03177610 |
| 44 | fatty acid oxidation (GO:0019395) | 4.02674495 |
| 45 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.02453881 |
| 46 | triglyceride catabolic process (GO:0019433) | 4.00453059 |
| 47 | triglyceride biosynthetic process (GO:0019432) | 3.96447270 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 3.96437064 |
| 49 | neutral lipid biosynthetic process (GO:0046460) | 3.95308546 |
| 50 | acylglycerol biosynthetic process (GO:0046463) | 3.95308546 |
| 51 | very long-chain fatty acid metabolic process (GO:0000038) | 3.92210588 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86945495 |
| 53 | neutral lipid catabolic process (GO:0046461) | 3.85796425 |
| 54 | acylglycerol catabolic process (GO:0046464) | 3.85796425 |
| 55 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.83571903 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 3.82929230 |
| 57 | gap junction assembly (GO:0016264) | 3.82331733 |
| 58 | reverse cholesterol transport (GO:0043691) | 3.82064354 |
| 59 | carnitine metabolic process (GO:0009437) | 3.81553414 |
| 60 | fatty acid catabolic process (GO:0009062) | 3.79915248 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.77809011 |
| 62 | triglyceride homeostasis (GO:0070328) | 3.75994882 |
| 63 | acylglycerol homeostasis (GO:0055090) | 3.75994882 |
| 64 | L-serine metabolic process (GO:0006563) | 3.75641599 |
| 65 | acetyl-CoA metabolic process (GO:0006084) | 3.74054165 |
| 66 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73589319 |
| 67 | heme transport (GO:0015886) | 3.71236604 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.70870411 |
| 69 | lysine metabolic process (GO:0006553) | 3.69752583 |
| 70 | lysine catabolic process (GO:0006554) | 3.69752583 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.68433491 |
| 72 | tryptophan catabolic process (GO:0006569) | 3.68099287 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.68099287 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 3.68099287 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.66859364 |
| 76 | positive regulation of fatty acid oxidation (GO:0046321) | 3.66389511 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.66052726 |
| 78 | negative regulation of lipase activity (GO:0060192) | 3.64235138 |
| 79 | alpha-amino acid catabolic process (GO:1901606) | 3.63749353 |
| 80 | regulation of protein activation cascade (GO:2000257) | 3.61788307 |
| 81 | triglyceride metabolic process (GO:0006641) | 3.58689155 |
| 82 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.58395580 |
| 83 | acyl-CoA metabolic process (GO:0006637) | 3.58285619 |
| 84 | thioester metabolic process (GO:0035383) | 3.58285619 |
| 85 | linoleic acid metabolic process (GO:0043651) | 3.54418262 |
| 86 | monocarboxylic acid catabolic process (GO:0072329) | 3.53993392 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.51778975 |
| 88 | bile acid metabolic process (GO:0008206) | 3.49394168 |
| 89 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.49271620 |
| 90 | ethanol metabolic process (GO:0006067) | 3.49146811 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.48447185 |
| 92 | organic acid catabolic process (GO:0016054) | 3.48447185 |
| 93 | regulation of complement activation (GO:0030449) | 3.44813725 |
| 94 | kynurenine metabolic process (GO:0070189) | 3.44189232 |
| 95 | tryptophan metabolic process (GO:0006568) | 3.44142549 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 3.44046073 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 3.42908119 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 3.42370011 |
| 99 | negative regulation of sterol transport (GO:0032372) | 3.42370011 |
| 100 | phospholipid efflux (GO:0033700) | 3.41078627 |
| 101 | protein carboxylation (GO:0018214) | 3.38247615 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.38247615 |
| 103 | regulation of cholesterol metabolic process (GO:0090181) | 3.38136189 |
| 104 | acylglycerol metabolic process (GO:0006639) | 3.37611844 |
| 105 | negative regulation of fibrinolysis (GO:0051918) | 3.36831282 |
| 106 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.36693737 |
| 107 | regulation of triglyceride metabolic process (GO:0090207) | 3.36419609 |
| 108 | urea cycle (GO:0000050) | 3.33352167 |
| 109 | urea metabolic process (GO:0019627) | 3.33352167 |
| 110 | cellular glucuronidation (GO:0052695) | 3.30342600 |
| 111 | regulation of water loss via skin (GO:0033561) | 3.20115032 |
| 112 | L-serine transport (GO:0015825) | 3.17375662 |
| 113 | regulation of hippo signaling (GO:0035330) | 3.11226582 |
| 114 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.08809367 |
| 115 | daunorubicin metabolic process (GO:0044597) | 3.04934121 |
| 116 | polyketide metabolic process (GO:0030638) | 3.04934121 |
| 117 | doxorubicin metabolic process (GO:0044598) | 3.04934121 |
| 118 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.97691368 |
| 119 | uronic acid metabolic process (GO:0006063) | 2.97323033 |
| 120 | glucuronate metabolic process (GO:0019585) | 2.97323033 |
| 121 | regulation of fibrinolysis (GO:0051917) | 2.94279741 |
| 122 | keratinocyte proliferation (GO:0043616) | 2.92656642 |
| 123 | intestinal cholesterol absorption (GO:0030299) | 2.91474800 |
| 124 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.83038627 |
| 125 | iron ion import (GO:0097286) | 2.82590687 |
| 126 | establishment of skin barrier (GO:0061436) | 2.81982563 |
| 127 | regulation of keratinocyte proliferation (GO:0010837) | 2.79053118 |
| 128 | nitrogen cycle metabolic process (GO:0071941) | 2.75802072 |
| 129 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.73853005 |
| 130 | polarized epithelial cell differentiation (GO:0030859) | 2.73844158 |
| 131 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.73620135 |
| 132 | fatty acid homeostasis (GO:0055089) | 2.69369840 |
| 133 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.69248392 |
| 134 | regulation of cholesterol homeostasis (GO:2000188) | 2.68575767 |
| 135 | drug transmembrane transport (GO:0006855) | 2.66973359 |
| 136 | Golgi transport vesicle coating (GO:0048200) | 2.66614510 |
| 137 | COPI coating of Golgi vesicle (GO:0048205) | 2.66614510 |
| 138 | tight junction assembly (GO:0070830) | 2.66500806 |
| 139 | cell-substrate adherens junction assembly (GO:0007045) | 2.65300604 |
| 140 | focal adhesion assembly (GO:0048041) | 2.65300604 |
| 141 | ER overload response (GO:0006983) | 2.64590851 |
| 142 | regulation of plasminogen activation (GO:0010755) | 2.60826952 |
| 143 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.57109321 |
| 144 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55453321 |
| 145 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.55308765 |
| 146 | intestinal absorption (GO:0050892) | 2.54853772 |
| 147 | COPII vesicle coating (GO:0048208) | 2.54804634 |
| 148 | negative regulation of fatty acid transport (GO:2000192) | 2.54766488 |
| 149 | endodermal cell differentiation (GO:0035987) | 2.53251679 |
| 150 | surfactant homeostasis (GO:0043129) | 2.51100454 |
| 151 | carnitine shuttle (GO:0006853) | 2.51078591 |
| 152 | epithelial cell-cell adhesion (GO:0090136) | 2.49086320 |
| 153 | notochord development (GO:0030903) | 2.41204871 |
| 154 | multicellular organismal water homeostasis (GO:0050891) | 2.40512099 |
| 155 | fatty acid transmembrane transport (GO:1902001) | 2.40257037 |
| 156 | adherens junction assembly (GO:0034333) | 2.37695974 |
| 157 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.36175690 |
| 158 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.36099160 |
| 159 | serine transport (GO:0032329) | 2.35696914 |
| 160 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.33704998 |
| 161 | chemical homeostasis within a tissue (GO:0048875) | 2.32526141 |
| 162 | activation of Rac GTPase activity (GO:0032863) | 2.32486722 |
| 163 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.32356431 |
| 164 | primary alcohol catabolic process (GO:0034310) | 2.31282052 |
| 165 | cell junction assembly (GO:0034329) | 2.30387609 |
| 166 | regulation of keratinocyte differentiation (GO:0045616) | 2.30290405 |
| 167 | protein retention in ER lumen (GO:0006621) | 2.29909897 |
| 168 | cell-cell junction assembly (GO:0007043) | 2.29379834 |
| 169 | fibrinolysis (GO:0042730) | 2.28242588 |
| 170 | mammary gland epithelial cell proliferation (GO:0033598) | 2.26084086 |
| 171 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.25071334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.60160032 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.26111260 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49732598 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.66815957 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.20058781 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.87864834 |
| 7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 4.17460825 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09332514 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.90623296 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.60285942 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.45126127 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.38213178 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99129549 |
| 14 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.73338344 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.64606193 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.44388036 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.43495503 |
| 18 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.33099638 |
| 19 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.33099638 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.31630627 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08721416 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.00274868 |
| 23 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.99467468 |
| 24 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.90566069 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85545542 |
| 26 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.67654956 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.62978718 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.59460113 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56716297 |
| 30 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.48182105 |
| 31 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48117450 |
| 32 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.47718827 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45972352 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44920597 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44590350 |
| 36 | ATF3_27146783_Chip-Seq_COLON_Human | 1.44237175 |
| 37 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.44138178 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.43384801 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.42074337 |
| 40 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40891837 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35943266 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35342755 |
| 43 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32384589 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32184731 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29790579 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28874232 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27966999 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19625778 |
| 49 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.19331977 |
| 50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19300389 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18114249 |
| 52 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18025802 |
| 53 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17563006 |
| 54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17127504 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16884171 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16627737 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14100954 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13518613 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12765565 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11509296 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11185356 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10522235 |
| 63 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09823612 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08344239 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07220551 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05514038 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05464242 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04749055 |
| 69 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04542399 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03990351 |
| 71 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03778674 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03341665 |
| 73 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.01791240 |
| 74 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99431487 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98715163 |
| 76 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98498808 |
| 77 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.97072826 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97070720 |
| 79 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93245031 |
| 80 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91974733 |
| 81 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91610139 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.88630941 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88499487 |
| 84 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86038521 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85341827 |
| 86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84556632 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84319763 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83512836 |
| 89 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82602330 |
| 90 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.81863049 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80498654 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80255279 |
| 93 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.80190214 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79600339 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79400044 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79400044 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79359327 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78536357 |
| 99 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78191690 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77656431 |
| 101 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.77498523 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77228917 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76887493 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76679025 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76524848 |
| 106 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75737708 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75730403 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75627353 |
| 109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74790857 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72289667 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71403280 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71386606 |
| 113 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.71149310 |
| 114 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68617682 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.67131443 |
| 116 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.66787942 |
| 117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63758440 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.61391673 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59966424 |
| 120 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.59150541 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57669559 |
| 122 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57360587 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.57356750 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.56315756 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.55969025 |
| 126 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.54754369 |
| 127 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.53535150 |
| 128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.53309067 |
| 129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52991317 |
| 130 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.52271502 |
| 131 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.52240288 |
| 132 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51756279 |
| 133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51465157 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51347475 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50873147 |
| 136 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.50645948 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.48959713 |
| 138 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.48688398 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48641731 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47336399 |
| 141 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.47163927 |
| 142 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.47025052 |
| 143 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.47025052 |
| 144 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.47025052 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.44864596 |
| 146 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.44845395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.38902254 |
| 2 | MP0005360_urolithiasis | 5.36948552 |
| 3 | MP0005365_abnormal_bile_salt | 4.46288612 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.29991289 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.76878905 |
| 6 | MP0005670_abnormal_white_adipose | 3.65844198 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.36016931 |
| 8 | MP0003941_abnormal_skin_development | 3.32338462 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.27084284 |
| 10 | MP0005409_darkened_coat_color | 3.12346171 |
| 11 | MP0005332_abnormal_amino_acid | 3.06907609 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.86393843 |
| 13 | MP0009840_abnormal_foam_cell | 2.82027225 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.72776291 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.67202025 |
| 16 | MP0003186_abnormal_redox_activity | 2.63733921 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.59091640 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.58566129 |
| 19 | MP0002796_impaired_skin_barrier | 2.46810055 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.42737530 |
| 21 | MP0002254_reproductive_system_inflammat | 2.35830323 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.31243298 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.29091722 |
| 24 | MP0004272_abnormal_basement_membrane | 2.27236855 |
| 25 | MP0003195_calcinosis | 2.24860139 |
| 26 | MP0003690_abnormal_glial_cell | 2.12452122 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.11544333 |
| 28 | MP0004130_abnormal_muscle_cell | 2.10029101 |
| 29 | MP0003011_delayed_dark_adaptation | 2.08638290 |
| 30 | MP0000762_abnormal_tongue_morphology | 1.92097208 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.89684730 |
| 32 | MP0003252_abnormal_bile_duct | 1.88438389 |
| 33 | MP0000467_abnormal_esophagus_morphology | 1.84631813 |
| 34 | MP0009053_abnormal_anal_canal | 1.81586734 |
| 35 | MP0000609_abnormal_liver_physiology | 1.81178452 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.80757416 |
| 37 | MP0002971_abnormal_brown_adipose | 1.77730672 |
| 38 | MP0005375_adipose_tissue_phenotype | 1.76881984 |
| 39 | MP0004782_abnormal_surfactant_physiolog | 1.69178638 |
| 40 | MP0001661_extended_life_span | 1.67292021 |
| 41 | MP0001764_abnormal_homeostasis | 1.58936116 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57260187 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.56929098 |
| 44 | MP0003329_amyloid_beta_deposits | 1.53518935 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.53335225 |
| 46 | MP0000627_abnormal_mammary_gland | 1.50245520 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.46660708 |
| 48 | MP0008057_abnormal_DNA_replication | 1.39841629 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.39222265 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.38040913 |
| 51 | MP0000566_synostosis | 1.36770324 |
| 52 | MP0005023_abnormal_wound_healing | 1.33846455 |
| 53 | MP0000604_amyloidosis | 1.27931130 |
| 54 | MP0000537_abnormal_urethra_morphology | 1.27287019 |
| 55 | MP0005501_abnormal_skin_physiology | 1.24540257 |
| 56 | MP0005647_abnormal_sex_gland | 1.23629541 |
| 57 | MP0001849_ear_inflammation | 1.22697614 |
| 58 | MP0005275_abnormal_skin_tensile | 1.22072635 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.21795485 |
| 60 | MP0005083_abnormal_biliary_tract | 1.21150234 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.20598422 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 1.19878406 |
| 63 | MP0009115_abnormal_fat_cell | 1.18976271 |
| 64 | MP0004043_abnormal_pH_regulation | 1.17243386 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.15538824 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.15436193 |
| 67 | MP0002009_preneoplasia | 1.13772725 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.12930384 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.12743437 |
| 70 | MP0005334_abnormal_fat_pad | 1.12429371 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 1.11373103 |
| 72 | MP0000462_abnormal_digestive_system | 1.07371770 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.06081725 |
| 74 | MP0005451_abnormal_body_composition | 1.04599198 |
| 75 | MP0000647_abnormal_sebaceous_gland | 1.02509762 |
| 76 | MP0002060_abnormal_skin_morphology | 1.02113819 |
| 77 | MP0005408_hypopigmentation | 1.00291903 |
| 78 | MP0005535_abnormal_body_temperature | 0.99459153 |
| 79 | MP0004233_abnormal_muscle_weight | 0.98887253 |
| 80 | MP0000579_abnormal_nail_morphology | 0.98472815 |
| 81 | MP0000383_abnormal_hair_follicle | 0.96579004 |
| 82 | MP0010678_abnormal_skin_adnexa | 0.96005131 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.95250814 |
| 84 | MP0004381_abnormal_hair_follicle | 0.94481675 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.88785400 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.88502718 |
| 87 | MP0004885_abnormal_endolymph | 0.88454038 |
| 88 | MP0002697_abnormal_eye_size | 0.88064648 |
| 89 | MP0001881_abnormal_mammary_gland | 0.87943033 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.87843610 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.87737597 |
| 92 | MP0009763_increased_sensitivity_to | 0.87736484 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.87375139 |
| 94 | MP0003091_abnormal_cell_migration | 0.87315083 |
| 95 | MP0006138_congestive_heart_failure | 0.86537035 |
| 96 | MP0001756_abnormal_urination | 0.85304146 |
| 97 | MP0002970_abnormal_white_adipose | 0.83205859 |
| 98 | MP0003075_altered_response_to | 0.82448602 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.81763186 |
| 100 | MP0009764_decreased_sensitivity_to | 0.80525223 |
| 101 | MP0000920_abnormal_myelination | 0.79201820 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.78188841 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 0.77965922 |
| 104 | MP0000598_abnormal_liver_morphology | 0.77558100 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.76499710 |
| 106 | MP0003718_maternal_effect | 0.76452171 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.75945973 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.75389827 |
| 109 | MP0009672_abnormal_birth_weight | 0.73881844 |
| 110 | MP0009931_abnormal_skin_appearance | 0.73139381 |
| 111 | MP0000427_abnormal_hair_cycle | 0.73134496 |
| 112 | MP0004147_increased_porphyrin_level | 0.73086304 |
| 113 | MP0003724_increased_susceptibility_to | 0.72634138 |
| 114 | MP0003868_abnormal_feces_composition | 0.72416874 |
| 115 | MP0004957_abnormal_blastocyst_morpholog | 0.71875393 |
| 116 | MP0003936_abnormal_reproductive_system | 0.71718487 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.71519005 |
| 118 | MP0003959_abnormal_lean_body | 0.69979479 |
| 119 | MP0010771_integument_phenotype | 0.68980785 |
| 120 | MP0003315_abnormal_perineum_morphology | 0.68354767 |
| 121 | MP0000367_abnormal_coat/_hair | 0.68149087 |
| 122 | MP0002086_abnormal_extraembryonic_tissu | 0.68117931 |
| 123 | MP0000377_abnormal_hair_follicle | 0.67920622 |
| 124 | MP0005164_abnormal_response_to | 0.67377159 |
| 125 | MP0001340_abnormal_eyelid_morphology | 0.67268238 |
| 126 | MP0003755_abnormal_palate_morphology | 0.66999533 |
| 127 | MP0005257_abnormal_intraocular_pressure | 0.66010443 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.65782899 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.65724518 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.64941392 |
| 131 | MP0005380_embryogenesis_phenotype | 0.63330136 |
| 132 | MP0001672_abnormal_embryogenesis/_devel | 0.63330136 |
| 133 | MP0002909_abnormal_adrenal_gland | 0.62837601 |
| 134 | MP0005395_other_phenotype | 0.62763291 |
| 135 | MP0009642_abnormal_blood_homeostasis | 0.62590086 |
| 136 | MP0003984_embryonic_growth_retardation | 0.61170203 |
| 137 | MP0001730_embryonic_growth_arrest | 0.61019211 |
| 138 | MP0002088_abnormal_embryonic_growth/wei | 0.60956319 |
| 139 | MP0001853_heart_inflammation | 0.60277390 |
| 140 | MP0005266_abnormal_metabolism | 0.60077075 |
| 141 | MP0008469_abnormal_protein_level | 0.59669755 |
| 142 | MP0003136_yellow_coat_color | 0.59306389 |
| 143 | MP0002295_abnormal_pulmonary_circulatio | 0.58566721 |
| 144 | MP0005197_abnormal_uvea_morphology | 0.58198955 |
| 145 | MP0002084_abnormal_developmental_patter | 0.58100277 |
| 146 | MP0003937_abnormal_limbs/digits/tail_de | 0.57820074 |
| 147 | MP0005165_increased_susceptibility_to | 0.55020701 |
| 148 | MP0005448_abnormal_energy_balance | 0.54919532 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.54318019 |
| 150 | MP0009697_abnormal_copulation | 0.53544327 |
| 151 | MP0001243_abnormal_dermal_layer | 0.51824924 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.49458078 |
| 153 | MP0000343_altered_response_to | 0.46807363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.64458653 |
| 2 | Abnormality of glycine metabolism (HP:0010895) | 5.37298182 |
| 3 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.37298182 |
| 4 | Xanthomatosis (HP:0000991) | 5.33619646 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 5.28751720 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 5.06247111 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.98008911 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.80146075 |
| 9 | Milia (HP:0001056) | 4.66999524 |
| 10 | Hyperglycinemia (HP:0002154) | 4.65099577 |
| 11 | Hyperammonemia (HP:0001987) | 4.61683422 |
| 12 | Deep venous thrombosis (HP:0002625) | 4.41543424 |
| 13 | Complement deficiency (HP:0004431) | 4.29636392 |
| 14 | Ketosis (HP:0001946) | 4.27907309 |
| 15 | Fragile nails (HP:0001808) | 4.22523365 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.19933802 |
| 17 | Atrophic scars (HP:0001075) | 4.00154899 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 3.95610514 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.88961805 |
| 20 | Plantar hyperkeratosis (HP:0007556) | 3.86853743 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.85744078 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83498919 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.82614035 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.82577448 |
| 25 | Epidermoid cyst (HP:0200040) | 3.69684523 |
| 26 | Ketoacidosis (HP:0001993) | 3.66446924 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.49990584 |
| 28 | Delayed CNS myelination (HP:0002188) | 3.47284039 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29892913 |
| 30 | Dicarboxylic aciduria (HP:0003215) | 3.28731248 |
| 31 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.28731248 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.20407400 |
| 33 | Hypertriglyceridemia (HP:0002155) | 3.19112930 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.18957819 |
| 35 | Neurofibrillary tangles (HP:0002185) | 3.14526363 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.14166025 |
| 37 | Pili torti (HP:0003777) | 3.13969812 |
| 38 | Abnormality of the axillary hair (HP:0100134) | 3.10978898 |
| 39 | Abnormality of secondary sexual hair (HP:0009888) | 3.10978898 |
| 40 | Alopecia of scalp (HP:0002293) | 3.10324277 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.08184484 |
| 42 | Abnormality of complement system (HP:0005339) | 3.05759494 |
| 43 | Hypoplasia of dental enamel (HP:0006297) | 2.97294958 |
| 44 | Flat acetabular roof (HP:0003180) | 2.90618583 |
| 45 | Lethargy (HP:0001254) | 2.89758381 |
| 46 | Acanthosis nigricans (HP:0000956) | 2.89483636 |
| 47 | Hypotrichosis (HP:0001006) | 2.88894677 |
| 48 | Pterygium (HP:0001059) | 2.88091172 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.82970278 |
| 50 | Nail dystrophy (HP:0008404) | 2.81286823 |
| 51 | Hypercholesterolemia (HP:0003124) | 2.80879320 |
| 52 | Ridged nail (HP:0001807) | 2.78368760 |
| 53 | Fat malabsorption (HP:0002630) | 2.77200685 |
| 54 | Amyloidosis (HP:0011034) | 2.73844372 |
| 55 | Abnormal hair laboratory examination (HP:0003328) | 2.63754817 |
| 56 | Palmoplantar hyperkeratosis (HP:0000972) | 2.59778895 |
| 57 | Abnormality of the common coagulation pathway (HP:0010990) | 2.58699335 |
| 58 | Vascular calcification (HP:0004934) | 2.57785214 |
| 59 | Parakeratosis (HP:0001036) | 2.57661504 |
| 60 | Metabolic acidosis (HP:0001942) | 2.56117043 |
| 61 | Myocardial infarction (HP:0001658) | 2.55623714 |
| 62 | Abnormality of the gastric mucosa (HP:0004295) | 2.55388692 |
| 63 | Methylmalonic aciduria (HP:0012120) | 2.51664025 |
| 64 | Palmar hyperkeratosis (HP:0010765) | 2.45238025 |
| 65 | Natal tooth (HP:0000695) | 2.45066800 |
| 66 | Pancreatitis (HP:0001733) | 2.44421235 |
| 67 | Sparse eyelashes (HP:0000653) | 2.43276922 |
| 68 | Mitral stenosis (HP:0001718) | 2.41064389 |
| 69 | Steatorrhea (HP:0002570) | 2.40817496 |
| 70 | Vomiting (HP:0002013) | 2.40770870 |
| 71 | Advanced eruption of teeth (HP:0006288) | 2.40753694 |
| 72 | Thick nail (HP:0001805) | 2.40275582 |
| 73 | Nausea (HP:0002018) | 2.40147442 |
| 74 | Joint hemorrhage (HP:0005261) | 2.38792996 |
| 75 | Woolly hair (HP:0002224) | 2.37520797 |
| 76 | Selective tooth agenesis (HP:0001592) | 2.36793974 |
| 77 | Brushfield spots (HP:0001088) | 2.36732841 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.34258213 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.33591842 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.33591842 |
| 81 | Cerebral edema (HP:0002181) | 2.33374735 |
| 82 | Fragile skin (HP:0001030) | 2.31681338 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.31575122 |
| 84 | Confusion (HP:0001289) | 2.28061915 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.25904956 |
| 86 | Arterial tortuosity (HP:0005116) | 2.25441414 |
| 87 | Abnormality of the intrinsic pathway (HP:0010989) | 2.24649815 |
| 88 | Onycholysis (HP:0001806) | 2.24416759 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.23541419 |
| 90 | Abnormality of carpal bone ossification (HP:0006257) | 2.23100583 |
| 91 | Short nail (HP:0001799) | 2.21287087 |
| 92 | Ankyloglossia (HP:0010296) | 2.20108237 |
| 93 | Amelogenesis imperfecta (HP:0000705) | 2.19152151 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 2.15549332 |
| 95 | Microglossia (HP:0000171) | 2.15290630 |
| 96 | Spastic paraparesis (HP:0002313) | 2.13323011 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.12947371 |
| 98 | Methylmalonic acidemia (HP:0002912) | 2.11315232 |
| 99 | Papillary thyroid carcinoma (HP:0002895) | 2.11274060 |
| 100 | Overlapping toe (HP:0001845) | 2.10866101 |
| 101 | Irritability (HP:0000737) | 2.09593133 |
| 102 | Premature rupture of membranes (HP:0001788) | 2.08543867 |
| 103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08193007 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.08193007 |
| 105 | Curly hair (HP:0002212) | 2.05902149 |
| 106 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.04491017 |
| 107 | Asymmetry of the thorax (HP:0001555) | 2.02203487 |
| 108 | Aplasia cutis congenita (HP:0001057) | 2.01378907 |
| 109 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00659245 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00659245 |
| 111 | Aplasia involving bones of the extremities (HP:0009825) | 2.00659245 |
| 112 | Increased muscle lipid content (HP:0009058) | 2.00413606 |
| 113 | Opisthotonus (HP:0002179) | 1.99518169 |
| 114 | Missing ribs (HP:0000921) | 1.98330609 |
| 115 | Vascular tortuosity (HP:0004948) | 1.98180347 |
| 116 | Hyperbilirubinemia (HP:0002904) | 1.97914021 |
| 117 | Hypoglycemic seizures (HP:0002173) | 1.95618266 |
| 118 | Pseudobulbar signs (HP:0002200) | 1.94811629 |
| 119 | Synostosis involving the elbow (HP:0003938) | 1.92926460 |
| 120 | Humeroradial synostosis (HP:0003041) | 1.92926460 |
| 121 | Respiratory distress (HP:0002098) | 1.92084930 |
| 122 | Absent eyelashes (HP:0000561) | 1.91823747 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91324385 |
| 124 | Abnormality of the nasal septum (HP:0000419) | 1.91159878 |
| 125 | Abnormality of oral frenula (HP:0000190) | 1.90878254 |
| 126 | Hypophosphatemic rickets (HP:0004912) | 1.90797239 |
| 127 | Abnormality of nail color (HP:0100643) | 1.89885097 |
| 128 | Abnormal hemoglobin (HP:0011902) | 1.89612125 |
| 129 | Malnutrition (HP:0004395) | 1.88140002 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 1.86059512 |
| 131 | Glycosuria (HP:0003076) | 1.86059512 |
| 132 | Back pain (HP:0003418) | 1.83459596 |
| 133 | Cheilitis (HP:0100825) | 1.83399787 |
| 134 | Coronal craniosynostosis (HP:0004440) | 1.83045255 |
| 135 | Abnormal ossification of hand bones (HP:0005921) | 1.82263879 |
| 136 | Late onset (HP:0003584) | 1.81806549 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.80369223 |
| 138 | Renal tubular acidosis (HP:0001947) | 1.79865274 |
| 139 | Rickets (HP:0002748) | 1.79573058 |
| 140 | Skin nodule (HP:0200036) | 1.79464602 |
| 141 | Coarse hair (HP:0002208) | 1.79070590 |
| 142 | Septate vagina (HP:0001153) | 1.78148551 |
| 143 | Focal segmental glomerulosclerosis (HP:0000097) | 1.78146261 |
| 144 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78131570 |
| 145 | Sensorimotor neuropathy (HP:0007141) | 1.77705601 |
| 146 | Spinal cord compression (HP:0002176) | 1.76955808 |
| 147 | Protrusio acetabuli (HP:0003179) | 1.74150805 |
| 148 | Delayed myelination (HP:0012448) | 1.73555849 |
| 149 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.73088279 |
| 150 | Gout (HP:0001997) | 1.72585104 |
| 151 | Lip pit (HP:0100267) | 1.72441297 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72342694 |
| 153 | Prenatal maternal abnormality (HP:0002686) | 1.72091279 |
| 154 | Potter facies (HP:0002009) | 1.71968521 |
| 155 | Facial shape deformation (HP:0011334) | 1.71968521 |
| 156 | Systemic lupus erythematosus (HP:0002725) | 1.71931879 |
| 157 | Coxa vara (HP:0002812) | 1.70318910 |
| 158 | Neonatal death (HP:0003811) | 1.69978265 |
| 159 | Abnormal blistering of the skin (HP:0008066) | 1.69879745 |
| 160 | Abnormal foot bone ossification (HP:0010675) | 1.68830528 |
| 161 | Blepharitis (HP:0000498) | 1.67537112 |
| 162 | Abnormal hand bone ossification (HP:0010660) | 1.64365255 |
| 163 | 11 pairs of ribs (HP:0000878) | 1.64113108 |
| 164 | Hyperparathyroidism (HP:0000843) | 1.63172047 |
| 165 | Micronodular cirrhosis (HP:0001413) | 1.62149550 |
| 166 | Hypoplastic labia majora (HP:0000059) | 1.62012660 |
| 167 | Facial hemangioma (HP:0000329) | 1.61936328 |
| 168 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.60950940 |
| 169 | Buphthalmos (HP:0000557) | 1.59785185 |
| 170 | Termporal pattern (HP:0011008) | 1.57432647 |
| 171 | Insidious onset (HP:0003587) | 1.57432647 |
| 172 | Cervical subluxation (HP:0003308) | 1.56134982 |
| 173 | Ulnar bowing (HP:0003031) | 1.55723080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 9.45674494 |
| 2 | SIK1 | 3.64585909 |
| 3 | ERN1 | 3.19582541 |
| 4 | SCYL2 | 3.19125734 |
| 5 | MAP3K9 | 2.85135736 |
| 6 | STK16 | 2.72522799 |
| 7 | CAMK1D | 2.64659664 |
| 8 | STK39 | 2.43160029 |
| 9 | TRIB3 | 2.24404211 |
| 10 | MET | 2.21729110 |
| 11 | PBK | 2.06883801 |
| 12 | MAP3K12 | 2.02928319 |
| 13 | MST1R | 2.00970108 |
| 14 | OXSR1 | 1.93015896 |
| 15 | FGFR2 | 1.89922826 |
| 16 | FGFR4 | 1.85048887 |
| 17 | RPS6KB2 | 1.82509428 |
| 18 | LATS1 | 1.76372137 |
| 19 | EEF2K | 1.66078065 |
| 20 | EIF2AK1 | 1.64068040 |
| 21 | CAMK1G | 1.60120492 |
| 22 | ICK | 1.58885728 |
| 23 | SMG1 | 1.58884918 |
| 24 | MAP3K2 | 1.56645520 |
| 25 | PDGFRA | 1.56263293 |
| 26 | CDK12 | 1.54321531 |
| 27 | PDK4 | 1.48255525 |
| 28 | PDK3 | 1.48255525 |
| 29 | EPHB1 | 1.46908065 |
| 30 | WNK4 | 1.45762022 |
| 31 | PAK4 | 1.42528533 |
| 32 | MST4 | 1.39261184 |
| 33 | LMTK2 | 1.38718079 |
| 34 | ARAF | 1.38292171 |
| 35 | EPHA4 | 1.32797758 |
| 36 | PRKAA2 | 1.32743939 |
| 37 | NTRK1 | 1.28404029 |
| 38 | EIF2AK3 | 1.18227523 |
| 39 | ABL2 | 1.17723823 |
| 40 | PIK3CG | 1.16069915 |
| 41 | PKN2 | 1.15910658 |
| 42 | ERBB4 | 1.10751611 |
| 43 | NEK1 | 1.08775258 |
| 44 | NEK6 | 1.06476560 |
| 45 | TAOK3 | 1.06248363 |
| 46 | PIK3CA | 1.06096471 |
| 47 | EPHA2 | 1.01984274 |
| 48 | TSSK6 | 0.99035787 |
| 49 | MAPK11 | 0.94193806 |
| 50 | TAF1 | 0.92927708 |
| 51 | IRAK3 | 0.92780947 |
| 52 | PNCK | 0.90715653 |
| 53 | PHKG2 | 0.90072144 |
| 54 | PHKG1 | 0.90072144 |
| 55 | STK38 | 0.89806509 |
| 56 | FER | 0.89174456 |
| 57 | MUSK | 0.86671286 |
| 58 | MELK | 0.86074196 |
| 59 | MAPK15 | 0.84833991 |
| 60 | MTOR | 0.84335080 |
| 61 | LRRK2 | 0.82361522 |
| 62 | TTK | 0.81488454 |
| 63 | PAK2 | 0.81147832 |
| 64 | BRSK2 | 0.80530058 |
| 65 | FLT3 | 0.80439156 |
| 66 | TRPM7 | 0.78246002 |
| 67 | PDK2 | 0.78235947 |
| 68 | IRAK1 | 0.78165610 |
| 69 | PDGFRB | 0.74308113 |
| 70 | PRKCI | 0.73839757 |
| 71 | CAMK2G | 0.73473502 |
| 72 | BCR | 0.73092746 |
| 73 | INSRR | 0.72389566 |
| 74 | MYLK | 0.70575174 |
| 75 | KSR2 | 0.70470015 |
| 76 | NEK9 | 0.70363272 |
| 77 | RIPK1 | 0.70003187 |
| 78 | PTK6 | 0.69660100 |
| 79 | TESK1 | 0.69489986 |
| 80 | STK10 | 0.69274028 |
| 81 | PINK1 | 0.69114886 |
| 82 | STK24 | 0.67243754 |
| 83 | CDK7 | 0.66086365 |
| 84 | TESK2 | 0.64794781 |
| 85 | IRAK2 | 0.64676907 |
| 86 | MAPKAPK3 | 0.62669785 |
| 87 | AKT3 | 0.62617934 |
| 88 | YES1 | 0.62375957 |
| 89 | MAP2K1 | 0.61358425 |
| 90 | TGFBR1 | 0.59516019 |
| 91 | BRAF | 0.59476309 |
| 92 | PRKACG | 0.59246845 |
| 93 | DDR2 | 0.57299215 |
| 94 | TNK2 | 0.57004958 |
| 95 | MAPK4 | 0.56184368 |
| 96 | PDPK1 | 0.55967043 |
| 97 | TYK2 | 0.55222572 |
| 98 | EIF2AK2 | 0.54251576 |
| 99 | STK38L | 0.54125670 |
| 100 | MAPKAPK5 | 0.52821965 |
| 101 | RPS6KB1 | 0.52777961 |
| 102 | CDC7 | 0.52336333 |
| 103 | RPS6KA2 | 0.52199976 |
| 104 | CSNK1G1 | 0.51957281 |
| 105 | MAP2K2 | 0.51545457 |
| 106 | PRKD3 | 0.51228026 |
| 107 | SGK3 | 0.50953998 |
| 108 | MAPK12 | 0.46717537 |
| 109 | TRIM28 | 0.46619268 |
| 110 | STK3 | 0.46431116 |
| 111 | LATS2 | 0.46389523 |
| 112 | IGF1R | 0.44860726 |
| 113 | WNK3 | 0.44026589 |
| 114 | EPHB2 | 0.43849424 |
| 115 | DAPK3 | 0.43790877 |
| 116 | AKT2 | 0.43489426 |
| 117 | AURKB | 0.43123943 |
| 118 | NTRK2 | 0.42837198 |
| 119 | DYRK2 | 0.42799489 |
| 120 | CAMK2B | 0.42251668 |
| 121 | JAK2 | 0.41997181 |
| 122 | MAP3K3 | 0.41961661 |
| 123 | PRKCQ | 0.41215651 |
| 124 | CDK19 | 0.41209561 |
| 125 | FGFR1 | 0.40337455 |
| 126 | WEE1 | 0.40179898 |
| 127 | FGR | 0.39756261 |
| 128 | MAP3K8 | 0.38620376 |
| 129 | MAP3K6 | 0.38197400 |
| 130 | RET | 0.37974896 |
| 131 | CDK6 | 0.37967222 |
| 132 | ILK | 0.37060039 |
| 133 | PRKCZ | 0.36651588 |
| 134 | GSK3A | 0.36450069 |
| 135 | PRKAA1 | 0.35294035 |
| 136 | KDR | 0.34726916 |
| 137 | PIM2 | 0.34364263 |
| 138 | CDK9 | 0.33904930 |
| 139 | CSNK1E | 0.33789600 |
| 140 | FGFR3 | 0.33707478 |
| 141 | PTK2 | 0.33534267 |
| 142 | SIK3 | 0.32921851 |
| 143 | PRKD1 | 0.31702161 |
| 144 | NME2 | 0.31692121 |
| 145 | DAPK2 | 0.30419458 |
| 146 | CAMK2D | 0.29347447 |
| 147 | WNK1 | 0.29115481 |
| 148 | TYRO3 | 0.29111829 |
| 149 | ADRBK1 | 0.27583655 |
| 150 | LIMK1 | 0.27400659 |
| 151 | CSNK1A1L | 0.26974092 |
| 152 | PRKG1 | 0.26792992 |
| 153 | BMX | 0.26143871 |
| 154 | SGK494 | 0.25703854 |
| 155 | SGK223 | 0.25703854 |
| 156 | PRKCA | 0.25145232 |
| 157 | CSF1R | 0.25102166 |
| 158 | CSNK1G3 | 0.24714470 |
| 159 | CSK | 0.24417169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.30752601 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10341881 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08503159 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.90974455 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.89866603 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89721469 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.76673241 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67131649 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.62212744 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49138954 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.47856317 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.41404688 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.32598002 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22432576 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04166079 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02377740 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97250894 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96595776 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.83549660 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81434241 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.79620357 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77199420 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76756166 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76741718 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70433739 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70347079 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68355892 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64172658 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63689194 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62955681 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58568872 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57116940 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51800813 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50357250 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.46153270 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.42532782 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36960832 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34158690 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31914359 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29526607 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28631321 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27961159 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25017579 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22660129 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.21287621 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19577319 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.16463274 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14808862 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14005622 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12384860 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11996892 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09004925 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08928724 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 1.08221733 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07225768 |
| 56 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.06504595 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05957866 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99199686 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99053156 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96553532 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95440228 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93821739 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93501577 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91667478 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91420125 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.90646014 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88860826 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88100544 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86475407 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85042037 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.82023169 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81623929 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.81605024 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78948244 |
| 75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73322971 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72731653 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71132837 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70326678 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65774516 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64117095 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63109277 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62685325 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62070478 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.61506287 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61498171 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57887373 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56445368 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55350370 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52833772 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52758338 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49663844 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.49242348 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48665010 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47317283 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46575640 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46239041 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45414282 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.45349592 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.44463962 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44450916 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44435047 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43310962 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43280920 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42936201 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41336279 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38208006 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33419109 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33053882 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30533261 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.22984529 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22799508 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.11375161 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10755594 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.10554648 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10036474 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10000333 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.09794824 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05587190 |
| 119 | Protein export_Homo sapiens_hsa03060 | 0.04920555 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.04834309 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02081036 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01974712 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0700454 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.0697840 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0624104 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0480669 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0289681 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | -0.0255631 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | -0.0174168 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0110370 |

